Replies to post #17169 on NorthWest Biotherapeutics Inc (NWBO)

[TOB]

Yes, there was an increase in Institutional Ownership as I Detailed Here.

As long as their level of conviction with the future success of NWBO trials and developments in Europe folds out successfully,they will buy in some size and obviously are price conscious as they diminish the float by taking it off the market. -maverick_1

However, the amounts we've seen so far are more likely the typical kneejerk reaction of Portfolio Managers to the Russel inclusion than any degree of confidence in the company. This happens to any company during a Russel Reconstitution and was expected. Some track the various Russell indices. It's good for NWBO to be included in the Russell, but not an indication of conviction for the portfolio managers, more herd following.

What you describe will be a healthy sign for NWBO, if and when it occurs, but the current status is very low Institutional Ownership/confidence in NWBO considering the Russel inclusion.

Currently, it appears the so called 'smart money' is predominantly short NWBO, as we know that shorting stocks is generally not a retail activity.

This does not necessarily indicate that the big money either short, or not buying NWBO, has an opinion on the success or failure of the clinical trial. It can also be an opinion that the company is likely to have delays in the trial completion and require significant fund raising. We already have found out about a delay of over a year in the trial.

So this would suggest the possibility of NWBO being at a lower share price prior to the clinical trial being near conclusion. If correct, this opinion would provide profits to the short seller, or give a cheaper entry price to the more patient long. It is possible to be positive the science and clinical trial result, but negative the short or mid-term share price.

Retail alternatively expects earth shattering news any day, thus will be long early, and hold through declines and warning signs. But if they get in ahead of significant institutional buying, then they can be well in profit. Hard to get lucky like that as often the early longs are badly damaged by dilution, reverse splits and so on. It's all about timing... ;-)